Selective serotonin reuptake inhibitors and fractures in older nursing home residents: Data from the INCUR study

Maturitas. 2022 Apr:158:37-39. doi: 10.1016/j.maturitas.2021.11.012. Epub 2021 Nov 21.

Abstract

Depression and selective serotonin reuptake inhibitors (SSRI) reduce bone mass and increase fracture risk. We analyzed the association between SSRI use and fractures development in nursing homes residents during a one-year prospective observational study. Sixty-four of the 800 participants developed a fracture during the one-year follow-up. Individuals who developed fractures used SSRIs more often than residents who did not (40.6% vs 28.7%, p =0.045). SSRIs were associated with fractures (adjusted OR 1.76, 95% CI 1.04 - 2.98, p = 0.036). A regular medication review should be performed to reduce inappropriate prescriptions and related adverse consequences.

Keywords: Fractures; Frailty; Older people; Osteoporosis; Residents; SSRI.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Bone Density
  • Fractures, Bone* / chemically induced
  • Fractures, Bone* / epidemiology
  • Humans
  • Nursing Homes
  • Prospective Studies
  • Selective Serotonin Reuptake Inhibitors* / adverse effects

Substances

  • Serotonin Uptake Inhibitors